What is hematocrit?
Hematocrit is the percentage of red blood cells by volume in your blood, measured through a standard blood test and routinely checked during testosterone replacement therapy.
Hematocrit represents the proportion of red blood cells in your total blood volume, expressed as a percentage. A lab technician draws blood and uses a centrifuge or automated analyzer to separate plasma from cells, then reports how much of the sample consists of red blood cells. Normal ranges typically fall between 41 and 50 percent for men, though this varies slightly by lab and individual factors like altitude and fitness level.
Testosterone replacement therapy can raise hematocrit levels because testosterone stimulates erythropoiesis, the body's production of red blood cells. While mild elevation is common and often benign, persistently high hematocrit thickens blood, increasing clotting risk and putting strain on the cardiovascular system. This risk grows as levels exceed 54 or 55 percent.
TRT providers in Miami monitor hematocrit through periodic blood work, typically every three to six months after starting therapy and annually during maintenance. If your level climbs too high, your provider may adjust your testosterone dose, extend the interval between injections, or recommend therapeutic phlebotomy (blood donation). Regular monitoring ensures you maintain the benefits of therapy while staying within a safe range. When seeking TRT providers, confirm they include hematocrit screening as part of their standard protocol.